
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Microalgal Oil
Therapeutic Area : Undisclosed
Study Phase : Phase III
Recipient : RDC Clinical
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Microalgal Oil is a Dietary Supplement drug candidate, which is currently being evaluated in Phase III clinical studies for the treatment of Absorption of Omega-3.
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
November 21, 2025
Lead Product(s) : Microalgal Oil
Therapeutic Area : Undisclosed
Highest Development Status : Phase III
Recipient : RDC Clinical
Deal Size : Inapplicable
Deal Type : Inapplicable
